Northern Star (ASX:NST) Up 64% in 2025: Buy the Dip at $25.50 or Wait for Better Entry?
Northern Star Resources (ASX: NST) has been one of the standout performers on the ASX in 2025, riding a powerful…
HMC Capital (ASX:HMC): Investors have sent it down 70% in a year but the CEO says it is performing…Who is right?
Between investors and HMC Capital’s management (especially David Di Pilla), they cannot both be right about the company. Investors have…
Altech Batteries (ASX: ATC): Buy the Dip or Avoid This Pre-Revenue Gamble?
Altech Batteries (ASX: ATC) presents investors with a classic pre-revenue dilemma: genuine technical progress meeting harsh commercial reality. Trading around…
Gentrack Rockets 22% on Record Results: Buy This Airport Software Stock or Sell Into the Rally?
Gentrack (ASX: GTK) jumped 22% to $8.10 today after reporting strong full-year results that beat market expectations. The New Zealand…
Pro Medicus Surges 3% on $29M US Contracts: Buy the Dip or Sell Into Strength at 200x Earnings?
Pro Medicus (ASX: PME) jumped 3% this morning to $258.50 after announcing $29 million in new US contracts spanning three…
Monash IVF Soars 40% After Rejecting $0.80 Takeover: Buy on Momentum or Sell Before Deal Collapses?
Monash IVF (ASX: MVF) surged 40% today to $0.855 after the company’s board unanimously rejected an $0.80-per-share takeover proposal from…
Qube Leaps 18% on A$5.20 Offer, Signalling ASX Infrastructure M&A Is Heating Up
Qube Surges 18% as Macquarie Moves to Snap Up Australia’s Logistics Backbone It seems as if the ASX M&A market…
Why Bitcoin Is Sliding, and Whether This Pullback Is a Buying Opportunity
Bitcoin Pullback Explained: Panic Signal or Prime Entry Point? Bitcoin (BTC-USD), often dubbed the digital gold standard, has seen a…
Monash IVF Shares Rocket 30% as the Board Rejects an A$0.80 Takeover Bid
Monash IVF Shares Soar on Bid Rejection, Board Says A$0.80 “Undervalues the Business” Shares in Monash IVF (ASX: MVF) delivered…
Does your company have an underperforming board? Here’s how to get rid of them: An s.249D notice!
Has your company got an underperforming board running your company and want to replace them? It’s possible and easy in…
Johnson and Johnson (NYSE:JNJ): Firmly on the Big Pharma M&A bandwagon
Johnson and Johnson (NYSE:JNJ) is arguably one of the big pharma companies least at risk from the Patent cliff. It…
Perseus Mining at All-Time High of $5.42: Lock in Profits or Hold for More?
Perseus Mining (ASX: PRU) hit an all-time high of $5.42 on November 13, completing a 104% rally that has rewarded…
Lovisa (ASX:LOV) AGM Today: Should You Buy This International Retail Success Story or Wait for a Pullback?
Lovisa Holdings (ASX: LOV) shares plunged 10% to around $31.45 today after the company released a trading update ahead of…
Mayne Pharma Surges on Takeover Panel Ruling: Buy for the 24% Upside or Too Risky?
Mayne Pharma (ASX: MYX) jumped 24% to $5.96 after the Takeovers Panel gave a ruling that may save its $672…